By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

S74.8 Injury of other nerves at hip and thigh level

AddAnalogsCompare
Found partially in the 50 (50) ⓘFound partially in the 50 drugs (50 of these, according to Kiberis statistics) in 0 selected books (authors) ... hide
  Effect Influence Cases ⓘ  Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • s74.8 injury of other nerves at hip and thigh level
  • 71%+4%9   Hidden. Need a subscription
    Hips - E 71% (I 4%, 9 cases.); Hip joint - E 62% (I 3%, 10 cases.)
  • 70%+9%4 read Cocculus indicus
  • 68%-9%7 read Cerebrum compositum n
  • 64%+7%8 read Plumbum metallicum
    Hips - E 64% (I 7%, 8 cases.); Hip joint - E 57% (I 4%, 5 cases.)
  • 63%+6%13 read Calcarea phosphorica
    Hips - E 63% (I 6%, 13 cases.); Hip joint - E 74% (I 4%, 10 cases.)
  • 60%-9%6 read Apis mellifica
  • 56%+2%8 read Mercurius solubilis
    Hips - E 56% (I 2%, 8 cases.); Hip joint - E 48% (I -3%, 7 cases.)
  • 55%-12%8 read Berberis vulgaris
  • 55%+7%13 read Discus compositum
    Hips - E 55% (I 7%, 13 cases.); Hip joint - E 56% (I 11%, 8 cases.)
  • 51%+16%40 read Pulsatilla nigricans
    Hips - E 51% (I 16%, 40 cases.); Hip joint - E 43% (I 9%, 30 cases.)
  • 50%-6%6 read Hepeel
  • 49%-8%9 read Chininum arsenicosum
    Hips - E 49% (I -8%, 9 cases.); Hip joint - E 34% (I -10%, 7 cases.)
  • 49%+10%30 read Lachesis muta
    Hips - E 49% (I 10%, 30 cases.); Hip joint - E 49% (I 13%, 23 cases.)
  • 48%+13%22 read Calcarea carbonica
    Hips - E 48% (I 13%, 22 cases.); Hip joint - E 46% (I 12%, 21 cases.)
  • 47%-4%10 read Zeel t
    Hips - E 47% (I -4%, 10 cases.); Hip joint - E 45% (I -1%, 9 cases.)
  • 47%+3%28 read Causticum hahnemanni
    Hips - E 47% (I 3%, 28 cases.); Hip joint - E 48% (I 1%, 24 cases.)
  • 46%+6%53 read Rhus toxicodendron
    Hips - E 46% (I 6%, 53 cases.); Hip joint - E 45% (I 4%, 41 cases.)
  • 46%+3%8 read Chelidonium majus
  • 46%+2%27 read Natrum muriaticum
    Hips - E 46% (I 2%, 27 cases.); Hip joint - E 47% (I 3%, 22 cases.)
  • 43%-12%10 read Echinacea compositum sn
    Hips - E 43% (I -12%, 10 cases.); Hip joint - E 73% (I 2%, 6 cases.)
  • 43%+0%6 read Carbo vegetabilis
    Hips - E 43% (I 0%, 6 cases.); Hip joint - E 37% (I 4%, 6 cases.)
  • 43%+0%33 read Lycopodium clavatum
    Hips - E 43% (I 0%, 33 cases.); Hip joint - E 42% (I -2%, 28 cases.)
  • 41%-5%35 read Kalium carbonicum
    Hips - E 41% (I -5%, 35 cases.); Hip joint - E 45% (I -3%, 30 cases.)
  • 41%-3%10 read Crotalus horridus
  • 40%+1%5 read Argentum nitricum
    Hips - E 40% (I 1%, 5 cases.); Hip joint - E 9% (I -15%, 4 cases.)
  • 40%+16%6 read Hepar sulphuris calcareum
  • 40%-11%9 read Cardiomil
    Hips - E 40% (I -11%, 9 cases.); Hip joint - E 33% (I -12%, 7 cases.)
  • 39%+0%24 read Arsenicum album
    Hips - E 39% (I 0%, 24 cases.); Hip joint - E 45% (I 8%, 15 cases.)
  • 39%+1%19 read Thuja occidentalis
    Hips - E 39% (I 1%, 19 cases.); Hip joint - E 8% (I -8%, 10 cases.)
  • 39%-10%7 read Colchicum autumnale
  • 38%-8%7 read Staphysagria
    Hips - E 38% (I -8%, 7 cases.); Hip joint - E 48% (I -8%, 5 cases.)
  • 37%+12%42 read Sulphur
    Hips - E 37% (I 12%, 42 cases.); Hip joint - E 42% (I 11%, 30 cases.)
  • 37%-5%7 read Sanguinaria canadensis
  • 36%+1%18 read Bryonia alba
    Hips - E 36% (I 1%, 18 cases.); Hip joint - E 38% (I -2%, 16 cases.)
  • 35%-8%22 read Arnica montana
    Hips - E 35% (I -8%, 22 cases.); Hip joint - E 30% (I -15%, 17 cases.)
  • 35%-5%11 read Silica terra
    Hips - E 35% (I -5%, 11 cases.); Hip joint - E 38% (I -6%, 10 cases.)
  • 33%+3%24 read Sepia officinalis
    Hips - E 33% (I 3%, 24 cases.); Hip joint - E 32% (I -3%, 16 cases.)
  • 32%-14%14 read Natrum sulphuricum
    Hips - E 32% (I -14%, 14 cases.); Hip joint - E 41% (I -6%, 11 cases.)
  • 31%-9%7 read Mucosa compositum
    Hips - E 31% (I -9%, 7 cases.); Hip joint - E 24% (I -14%, 5 cases.)
  • 31%-14%4 read Aurum metallicum
    Hips - E 31% (I -14%, 4 cases.); Hip joint - E 31% (I -14%, 4 cases.)
  • 30%-7%6 read Gelsemium sempervirens
    Hips - E 30% (I -7%, 6 cases.); Hip joint - E 44% (I 7%, 5 cases.)
  • 30%-10%4 read Psorinum
  • 29%-4%8 read Conium maculatum
    Hips - E 29% (I -4%, 8 cases.); Hip joint - E 26% (I -5%, 9 cases.)
  • 29%+2%32 read Phosphorus
    Hips - E 29% (I 2%, 32 cases.); Hip joint - E 36% (I 3%, 25 cases.)
  • 20%+0%10 read Nux vomica
    Hips - E 20% (I 0%, 10 cases.); Hip joint - E 26% (I 3%, 8 cases.)
  • 19%-1%6 read Tuberculinum
  • 18%+4%10 read Rhododendron chrysanthum
    Hips - E 18% (I 4%, 10 cases.); Hip joint - E 20% (I 7%, 9 cases.)
  • 17%-2%6 read Graphites naturalis
  • 17%-16%6 read Medorrhinum
  • -10%-8%5 read Ignatia amara

Tree of ICD-10 diagnoses

  1. Description
  2. Similar diseases
  3. Related standards of medical care
  4. Basic medical services
  5. Clinics for treatment

Other names and synonyms

S74.8.

Description

There is no detailed description, see related

Similar diseases

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.